Navigation Links
Milestone of 3,000 USP Reference Standards
Date:3/5/2013

Rockville, MD (PRWEB) March 05, 2013

In a milestone representing a significant contribution to public health, the U.S. Pharmacopeial Convention (USP) announces that it has grown its portfolio of reference standards to now include 3,000 items. USP Reference Standards are highly characterized samples of active pharmaceutical ingredients and impurities, food chemicals, and dietary supplements and their ingredients. Regulators and manufacturers use USP Reference Standards to assess products’ conformity to standards of identity, quality, purity and strength. USP Reference Standards are specified in the monographs of the U.S. Pharmacopeia and National Formulary (USP–NF), USP’s flagship compendia of quality standards; the Food Chemicals Codex (for food ingredients), the Dietary Supplements Compendium, and the new Medicines Compendium. Drugs sold or manufactured in the United States are required by law to comply with standards published in the USP–NF, and these standards are enforceable by the Food and Drug Administration.

“Attaining 3,000 USP Reference Standards is important for USP, of course, but also for all stakeholders interested in advancing public health,” said Roger L. Williams, M.D., chief executive officer at USP. “USP relies on our volunteer experts who, with staff, set the standards, and on the manufacturers who donate the monographs and materials from which many of our standards are derived. Both are equally crucial in the standards-setting process, and I want to take this opportunity to thank all who understand the importance of public standards.”

Dr. Williams also noted USP’s focused effort over the last decade to strengthen USP’s public standards. This effort is ongoing, and is summarized in USP’s policy statements and in a stimuli article.

USP distributes thousands of units of its Reference Standards every year to customers in more than 140 countries around the world. The breadth and depth of the USP catalog means that regulators and manufacturers have the fullest available complement of publicly available standards to help ensure the quality of medicines, foods and dietary supplements throughout the supply chain, from manufacturers to practitioners, patients and consumers.

For more information, please visit http://www.usp.org/usp-nf. Media inquiries may be directed to mediarelations(at)usp(dot)org.

###

USP—Advancing Public Health Since 1820
The United States Pharmacopeial (USP) Convention is a scientific, nonprofit, standards-setting organization that advances public health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. USP's standards are recognized and used worldwide. For more information about USP visit http://www.usp.org.

Read the full story at http://www.prweb.com/releases/3000/ReferenceStandards/prweb10498344.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GenVec Achieves Second Milestone in Collaboration
2. Kensey Nash Corporation Announces Achievement of $6 Million Milestone From Spectranetics Corporation
3. Start of Phase IIa Study in Acute Lung Injury Patients Marks Development Milestone
4. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
5. CitiusTech Completes Another Milestone Year: Revenues Grow by 59% in 2011
6. BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
7. AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001
8. Cobalt Technologies Hits Key Commercial Milestone with Pretreatment Process Demonstration
9. Cell Therapeutics, Inc. (CTI) Reports First Quarter Financial Results and Milestones
10. Northwest Bio and Fraunhofer IZI Announce Milestones Reached
11. A milestone in nanoparticle research: Nanoparticle test handbook sets the standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... During ... connected digital health applications, announced a partnership with Redox, a leader in cloud-based ... to many clinical systems while keeping data secure in the cloud. , The ...
(Date:2/21/2017)... ... February 21, 2017 , ... With ... operational capacity with its strategic internal leadership to provide clients with best ... operational management. With office locations in North Carolina, Massachusetts, Ohio, Illinois, ...
(Date:2/21/2017)... , Feb. 21, 2017   Logicalis Healthcare Solutions ... IT solutions and managed services provider ( www.us.logicalis.com ), ... Desk for Epic. The new service will help hospital ... resources by giving physicians, nurses and other clinicians immediate ... tier-one support. This will allow hospital IT staff to ...
(Date:2/20/2017)... - BioAmber Inc. (NYSE: BIOA ) announced today that Jean-Francois ... the company,s COO, has been named President, effective immediately.  ... Fabrice has overseen the construction, start-up and operation of the manufacturing ... the Mitsui JV.  Fabrice has also been extensively involved in the ... ...
Breaking Biology Technology:
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
Breaking Biology News(10 mins):